A novel paradigm for effective and safer treatment of schizophrenia: biased (ant)agonists with a characterized polypharmacological profile (PSYBIAS)
- Researcher(s):
- J. Selent (I.P.), J.J. Meana (Investigador responsable en la Universidad del País Vasco / Euskal Herriko Unibertsitatea)
- Period:
- from 2019 to 2021
- Financing entity:
- ERANET Neuron
- Description:
-
Joint project with Medical Research Institute of Barcelona, Philipps- Universität Marburg and University of Montreal.